Hello, Guest
Login
Sign Up
 
 

Nanocap Stocks Buzz: IKONICS Corporation, SPAR Group, Lightbridge Corp, Genetic Technologies Limited

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 02/28/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

IKONICS Corporation(NASDAQ:IKNX) added 1.53% and is trading at $87.82. IKONICS Corporation (IKONICS) is engaged in the development, manufacture and selling of photosensitive liquids (emulsions) and films for the screen printing and awards and recognition industries. IKONICS's Micro-Machining business unit uses its patent applied for photoresist film for the abrasive etching of silicon wafers, glass wafers, industrial ceramics and composite materials.

How Should Investors Trade IKNX After The Recent Movement? Find Out Here

SPAR Group, Inc.(NASDAQ:SGRP) is lower 3.13% and is trading at $1.83. SPAR Group, Inc., (SGRP) is a diversified international merchandising and marketing services company and provides an array of services worldwide. The Company provides its merchandising and other marketing services to manufacturers, distributors and retailers worldwide, primarily in mass merchandisers, office supply, grocery, drug store and other chains, and independent, convenience and electronics stores.

Is SGRP Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Lightbridge Corp(NASDAQ:LTBR) added 12.07% and is trading at $2.32. Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company. The Company operates in two segments: nuclear fuel technology business segment and nuclear consulting business segment. In nuclear fuel technology business segment it develops next generation nuclear fuel technology.

Is LTBR a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Genetic Technologies Limited (ADR)(NASDAQ:GENE) is higher 3.20% and is trading at $2.58. Genetic Technologies Limited (GTG) is engaged the provision of genetic testing services. The Company also conducts out-licensing program in respect of its non-coding deoxyribonucleic acid technology and supports a late-stage research project. The Company operates in three segments: Operations, Licensing and Research.

How Should Investors Trade GENE After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.